X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-15 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $20.76 | -12,000 | 435,334 | -3% | -$249,121 | ||||||
2024-06-12 | ARCT | Sassine Andy | CFO | S - Sale | $32.03 | -50,000 | 220,526 | -18% | -$1,601,500 | ||||||
2024-06-05 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $45.00 | -114 | 447,334 | 0% | -$5,130 | ||||||
2024-06-03 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $40.01 | -26,000 | 447,448 | -5% | -$1,040,234 | ||||||
2024-03-25 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $35.02 | -17,435 | 473,448 | -4% | -$610,574 | ||||||
2024-03-19 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $35.01 | -8,565 | 490,883 | -2% | -$299,839 | ||||||
2023-11-01 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $18.72 | -5,000 | 499,448 | -1% | -$93,602 | ||||||
2023-10-02 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $25.61 | -5,000 | 504,448 | -1% | -$128,062 | ||||||
2023-09-01 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $31.45 | -5,000 | 509,448 | -1% | -$157,264 | ||||||
2023-08-01 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $34.91 | -5,000 | 514,448 | -1% | -$174,550 | ||||||
2023-07-14 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $35.01 | -25,000 | 519,448 | -5% | -$875,250 | ||||||
| D | 2023-07-14 | ARCT | Kummerfeld Keith C | See Remarks | S - Sale+OE | $35.00 | -6,968 | 950 | -88% | -$243,880 | |||||
2023-07-03 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $28.75 | -5,000 | 544,448 | -1% | -$143,750 | ||||||
2023-06-01 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $27.16 | -5,000 | 549,448 | -1% | -$135,800 | ||||||
| M | 2023-05-10 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $30.08 | -25,000 | 554,448 | -4% | -$751,902 | |||||
2023-05-01 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $25.93 | -5,000 | 579,448 | -1% | -$129,650 | ||||||
| D | 2023-04-18 | ARCT | Kummerfeld Keith C | See Remarks | S - Sale+OE | $28.18 | -6,968 | 950 | -88% | -$196,358 | |||||
2023-04-03 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $25.38 | -5,000 | 584,448 | -1% | -$126,900 | ||||||
2023-03-06 | ARCT | Chivukula Pad | Chief Scientific Officer, COO | S - Sale | $16.07 | -5,000 | 589,448 | -1% | -$80,350 | ||||||
2022-12-15 | ARCT | Marquet Magda | Dir | P - Purchase | $18.00 | +2,222 | 24,942 | +10% | +$39,996 | ||||||
2022-11-23 | ARCT | Payne Joseph E | Pres, CEO | P - Purchase | $16.51 | +5,000 | 1,480,097 | 0% | +$82,550 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |